MacroGenics
MGNX
#9452
Rank
NZ$0.22 B
Marketcap
NZ$3.58
Share price
-1.01%
Change (1 day)
41.09%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.22 Billion

As of November 2026 MacroGenics has a market cap of NZ$0.22 Billion. This makes MacroGenics the world's 9452th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.22 B30.21%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.22 Billion
by Nasdaq info icon info icon
NZ$0.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$285.48 B 124,579.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.193 T 957,840.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$430.75 B 188,020.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$377.35 B 164,698.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$602.60 B 263,071.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$219.71 B 95,853.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$4.56 B 1,892.49%๐Ÿ‡บ๐Ÿ‡ธ USA